comparemela.com

Latest Breaking News On - அறுவை சிகிச்சை உளவுத்துறை - Page 1 : comparemela.com

Theator Appoints Kavi Vyas as Chief Commercial Officer

Theator Named to the 2021 CB Insights AI 100 List of Most Innovative Artificial Intelligence Startups

Theator Named to the 2021 CB Insights AI 100 List of Most Innovative Artificial Intelligence Startups USA - English News provided by Share this article AI 100 ranking, showcasing the 100 most promising private artificial intelligence companies in the world. This is the fifth year CB Insights has recognized the most promising private artificial intelligence companies with the AI 100, and this is one of the most global groups we ve ever seen. This year s cohort spans 18 industries, and is working on everything from climate risk to accelerating drug R&D, said CB Insights CEO Anand Sanwal. Last year s AI 100 companies had a remarkable run after being named to the list, with more than 50% going on to raise additional financing (totaling $5.2B), including 16 $100 million+ mega-rounds. Many also went on to exit via M&A, SPAC or IPO. As industry after industry adopts AI, we expect this year s class will see similar levels of interest from investors, acquirers and customers.

Follow the Money: Single-Cell Multiomics, Data Networks, Security

April 1, 2021 By Bio-IT World Staff April 1, 2021 | New investment funds for late-stage companies and public health. Next-gen genomic medicines and single-cell multiomics get cash, and PatientsLikeMe raises a new round of funding to expand.   $969M Investment Fund for Early to Late-Stage Companies Foresite Capital, a multi-stage healthcare and life sciences investment firm, has announced its fifth and largest fundraise with $969 million in capital commitments, significantly oversubscribed above its original target. The offering comprises Foresite Capital Fund V, L.P. and Foresite Capital Opportunity Fund V, L.P. With these new funds, Foresite Capital is investing in emerging healthcare and life sciences companies at all stages that are solving some of the biggest inefficiencies and pain points of the $10 trillion global healthcare market. Foresite Capital now has ~$4 billion in assets under management. Press release.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.